Literature DB >> 19499250

[Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases].

R Nickel1, J Hardt, B Kappis, R Schwab, U T Egle.   

Abstract

According to a population-based prevalence study, medically unexplained pain syndromes are highly prevalent in the German general population. With a 1-year prevalence of 8% for somatoform pain disorders and a lifetime prevalence of 12.7%, they rank among the most prevalent conditions in the community. Until now, few studies have been conducted to characterize and differentiate patients with somatoform pain disorders in more detail. The present study is the first to examine a large patient cohort from a university hospital outpatient unit with somatoform disorders presenting with pain as the predominant complaint (n=282). Patients with a nociceptive or neuropathic pain mechanism were excluded after interdisciplinary diagnostic procedures, and all patients were differentiated in terms of comorbid psychic disorders and their symptom presentation. Psychic disorders were assessed using a standardized structured interview (SCID-I and SCID-II) and a structured biographical case history (MSBI) to assess chronification factors. The extent and distribution of bodily symptoms were collected using the screening for somatoform disorders (SOMS). A total of 69% of the patients examined suffered from anxiety and depressive disorders or other mental disorders, and only 14% had a comorbid personality disorder. More than 90% had further bodily symptoms apart from pain. The presence of mental disorders and the duration of the illness were associated with a higher number of bodily symptoms (e.g., fatigue, dizziness), for which they may also consult a doctor. In addition, the frequency of fibromyalgia syndrome increases with the extent of somatization. Our results ultimately support the idea of classifying this group of patients as an independent diagnostic group. They further suggest a future differentiation regarding the degree of impairment within this group similar to the systems of stages used in depressive disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19499250     DOI: 10.1007/s00482-009-0805-6

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  43 in total

1.  Somatoform disorders and DSM-V: conceptual and political issues in the debate.

Authors:  Vladan Starcevic
Journal:  Psychosomatics       Date:  2006 Jul-Aug       Impact factor: 2.386

2.  Somatoform disorder in primary care: course and the need for cognitive-behavioral treatment.

Authors:  Ingrid A Arnold; Margot W M de Waal; Just A H Eekhof; Albert M van Hemert
Journal:  Psychosomatics       Date:  2006 Nov-Dec       Impact factor: 2.386

Review 3.  DSM-IV pain disorder in the general population. An exploration of the structure and threshold of medically unexplained pain symptoms.

Authors:  Christine Fröhlich; Frank Jacobi; Hans-Ulrich Wittchen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-11-18       Impact factor: 5.270

4.  Placebo effects on human mu-opioid activity during pain.

Authors:  Tor D Wager; David J Scott; Jon-Kar Zubieta
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

5.  Pain induced by low-grade stress in patients with fibromyalgia and chronic shoulder/neck pain, relation to surface electromyography.

Authors:  K B Nilsen; R H Westgaard; L J Stovner; G Helde; M Rø; T H Sand
Journal:  Eur J Pain       Date:  2005-11-21       Impact factor: 3.931

6.  [Psychosomatic rehabilitation of in-patients with somatoform disorders and of patients with social-medically relevant problems: results of a two-year follow-up].

Authors:  C Hoffmann; W Ruf-Ballauf
Journal:  Rehabilitation (Stuttg)       Date:  2007-10       Impact factor: 1.113

Review 7.  Psychosomatic syndromes, somatization and somatoform disorders.

Authors:  R Kellner
Journal:  Psychother Psychosom       Date:  1994       Impact factor: 17.659

8.  Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety.

Authors:  Monika Mussell; Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Wolfgang Herzog; Bernd Löwe
Journal:  J Psychosom Res       Date:  2008-04-28       Impact factor: 3.006

Review 9.  Stability of somatoform symptoms--implications for classification.

Authors:  Winfried Rief; Graciela Rojas
Journal:  Psychosom Med       Date:  2007-12       Impact factor: 4.312

10.  Cerebral activation in patients with somatoform pain disorder exposed to pain and stress: an fMRI study.

Authors:  P Stoeter; Th Bauermann; R Nickel; L Corluka; J Gawehn; G Vucurevic; G Vossel; U T Egle
Journal:  Neuroimage       Date:  2007-02-27       Impact factor: 6.556

View more
  4 in total

Review 1.  Somatoform abdominal pain in surgery: is SD worthy of surgical attention? Case reports and literature review.

Authors:  Sami Medani Abd Elwahab; Eva Doherty; Hashim Elsheikh
Journal:  BMJ Case Rep       Date:  2012-08-24

2.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

3.  [Aspects of liaison psychiatry care of patients in a university pain clinic].

Authors:  M Brinkers; G Pfau; C Schneemilch
Journal:  Schmerz       Date:  2018-04       Impact factor: 1.107

4.  [Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].

Authors:  W Häuser; U Marschall; H L'hoest; K Komossa; P Henningsen
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.